Towards a multi protein and mRNA expression of biological predictive and distinguish model for post stroke depression

Oncotarget

Volumn 7, Issue 34, 2016, Pages 54329-54338

  Yue, Yingying ^a   Jiang, Haitang ^a   Liu, Rui ^b   Yin, Yingying ^a   Zhang, Yuqun ^a   Liang, Jinfeng ^a   Li, Shenghua ^c   Wang, Jun ^d   Lu, Jianxin ^e   Geng, Deqin ^f   Wu, Aiqin ^g   Yuan, Yonggui ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c Department of Respiratory Medicine Nanjing Jiangning Hospital   (China)

^d THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^e Jiangsu Jiankang Professional College   (China)

^f XUZHOU MEDICAL UNIVERSITY   (China)

^g THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

MRNA; Neurotrophic factors; Pathology Section; Post stroke depression; Protein

Indexed keywords

MESSENGER RNA; PLACENTAL GROWTH FACTOR; SOMATOMEDIN C; SOMATOMEDIN RECEPTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; IGF1 PROTEIN, HUMAN; IGF1R PROTEIN, HUMAN; MEMBRANE PROTEIN; PIGF PROTEIN, HUMAN;

ADULT; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PATHOGENESIS; POST STROKE DEPRESSION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEIVER OPERATING CHARACTERISTIC; AGED; DEPRESSION; GENETICS; METABOLISM; MIDDLE AGED; PSYCHOLOGY;

AGED; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MEMBRANE PROTEINS; MIDDLE AGED; RECEPTORS, SOMATOMEDIN; RNA, MESSENGER; STROKE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84983546305     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.11105     Document Type: Article

References (48)

1. Liu L, Wang D, Wong KS and Wang Y. Stroke and stroke care in China: huge burden, significant workload, and a national priority. Stroke. 2011; 42:3651-3654.
2. de Man-van Ginkel JM, Hafsteinsdottir TB, Lindeman E, Ettema RG, Grobbee DE and Schuurmans MJ. In-Hospital Risk Prediction for Post-stroke Depression: Development and Validation of the Post-stroke Depression Prediction Scale. Stroke. 2013; 44:2441-2445.
3. Pompili M, Venturini P, Campi S, Seretti ME, Montebovi F, Lamis DA, Serafini G, Amore M and Girardi P. Do stroke patients have an increased risk of developing suicidal ideation or dying by suicide? An overview of the current literature. CNS neurosci Ther. 2012; 18:711-721.
4. Zhang N, Wang CX, Wang AX, Bai Y, Zhou Y, Wang YL, Zhang T, Zhou J, Yu X, Sun XY, Liu ZR, Zhao XQ and Wang YJ. Time course of depression and one-year prognosis of patients with stroke in mainland China. CNS Neurosci Ther. 2012; 18:475-481.
5. Yuan HW, Wang CX, Zhang N, Bai Y, Shi YZ, Zhou Y, Wang YL, Zhang T, Zhou J, Yu X, Sun XY, Liu ZR, Zhao XQ and Wang YJ. Poststroke depression and risk of recurrent stroke at 1 year in a Chinese cohort study. PloS one. 2012; 7:e46906.
6. Loubinoux I, Kronenberg G, Endres M, Schumann-Bard P, Freret T, Filipkowski RK, Kaczmarek L and Popa-Wagner A. Post-stroke depression: mechanisms, translation and therapy. J Cell Mol Med. 2012; 16:1961-1969.
7. Newton SS, Fournier NM and Duman RS. Vascular growth factors in neuropsychiatry. Cell Mol Life Sci. 2013; 70:1739-1752.
8. Ruiz de Almodovar C, Lambrechts D, Mazzone M and Carmeliet P. Role and therapeutic potential of VEGF in the nervous system. Physiol Rev. 2009; 89:607-648.
9. Chen J, Zhang C, Jiang H, Li Y, Zhang L, Robin A, Katakowski M, Lu M and Chopp M. Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. J Cereb Blood Flow Metab. 2005; 25:281-290.
10. Greenberg DA and Jin K. Vascular endothelial growth factors (VEGFs) and stroke. Cell Mol Life Sci. 2013; 70:1753-1761.
11. Lee BH and Kim YK. Increased plasma VEGF levels in major depressive or manic episodes in patients with mood disorders. J Affect Disorders. 2012; 136:181-184.
12. Ferrara N. Vascular endothelial growth factor: basic science and clinical progress. Endocrine reviews. 2004; 25:581-611.
13. Minchenko A, Salceda S, Bauer T and Caro J. Hypoxia regulatory elements of the human vascular endothelial growth factor gene. Cell Mol Biol Res 1994; 40:35-39.
14. Jin K, Zhu Y, Sun Y, Mao XO, Xie L and Greenberg DA. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci U S A. 2002; 99:11946-11950.
15. Warner-Schmidt JL and Duman RS. VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants. Proc Natl Acad Sci U S A. 2007; 104:4647-4652.
16. Krupinski J, Kaluza J, Kumar P, Kumar S and Wang JM. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke. 1994; 25:1794-1798.
17. Marti HJ, Bernaudin M, Bellail A, Schoch H, Euler M, Petit E and Risau W. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol. 2000; 156:965-976.
18. Berent D, Macander M, Szemraj J, Orzechowska A and Galecki P. Vascular endothelial growth factor A gene expression level is higher in patients with major depressive disorder and not affected by cigarette smoking, hyperlipidemia or treatment with statins. Acta Neurobiol Exp. 2014; 74:82-90.
19. Galecki P, Orzechowska A, Berent D, Talarowska M, Bobinska K, Galecka E, Lewinski A, Maes M and Szemraj J. Vascular endothelial growth factor receptor 2 gene (KDR) polymorphisms and expression levels in depressive disorder. J Affect Disorders. 2013; 147:144-149.
20. Clark-Raymond A and Halaris A. VEGF and depression: a comprehensive assessment of clinical data. J Psychiat Res. 2013; 47:1080-1087.
21. Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med. 2001; 7:575-583.
22. Szczesny E, Slusarczyk J, Glombik K, Budziszewska B, Kubera M, Lason W and A B-K. Possible contribution of IGF-1 to depressive disorder. Pharmacol Rep. 2013; 65:1622-1631.
23. Lee KY, Miki T, Yokoyama T, Ueki M, Warita K, Suzuki S, Ohta K, Wang ZY, Jamal M, Yakura T, Liu JQ, Hosomi N and Takeuchi Y. Neonatal repetitive maternal separation causes long-lasting alterations in various neurotrophic factor expression in the cerebral cortex of rats. Life Sci. 2012; 90:578-584.
24. Yau SY, Li A, Zhang ED, Christie BR, Xu A, Lee TM and So KF. Sustained running in rats administered corticosterone prevents the development of depressive behaviors and enhances hippocampal neurogenesis and synaptic plasticity without increasing neurotrophic factor levels. Cell Transplant. 2014; 23:481-492.
25. Trejo JL, Llorens-Martin MV and Torres-Aleman I. The effects of exercise on spatial learning and anxiety-like behavior are mediated by an IGF-I-dependent mechanism related to hippocampal neurogenesis. Mol Cell Neurosci. 2008; 37:402-411.
26. Palomino A, Gonzalez-Pinto A, Martinez-Cengotitabengoa M, Ruiz de Azua S, Alberich S, Mosquera F and Matute C. Relationship between negative symptoms and plasma levels of insulin-like growth factor 1 in first-episode schizophrenia and bipolar disorder patients. Prog Neuropsychopharmacology Biol psychiatry. 2013; 44:29-33.
27. Weber-Hamann B, Blum WF, Kratzsch J, Gilles M, Heuser I and Deuschle M. Insulin-like growth factor-I (IGF-I) serum concentrations in depressed patients: relationship to saliva cortisol and changes during antidepressant treatment. Pharmacopsychiatry. 2009; 42:23-28.
28. Pilar-Cuellar F, Vidal R, Diaz A, Castro E, dos Anjos S, Pascual-Brazo J, Linge R, Vargas V, Blanco H, Martinez-Villayandre B, Pazos A and Valdizan EM. Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication. Neural plasticity. 2013; 2013:537265.
29. Carvalho AF, Kohler CA, McIntyre RS, Knochel C, Brunoni AR, Thase ME, Quevedo J, Fernandes BS and Berk M. Peripheral vascular endothelial growth factor as a novel depression biomarker: A meta-analysis. Psychoneuroendocrinology. 2015; 62:18-26.
30. Ventriglia M, Zanardini R, Pedrini L, Placentino A, Nielsen MG, Gennarelli M and Bocchio-Chiavetto L. VEGF serum levels in depressed patients during SSRI antidepressant treatment. Prog Neuropsychopharmacology Biol psychiatry. 2009; 33:146-149.
31. Heine VM, Zareno J, Maslam S, Joels M and Lucassen PJ. Chronic stress in the adult dentate gyrus reduces cell proliferation near the vasculature and VEGF and Flk-1 protein expression. Eur J Neurosci. 2005; 21:1304-1314.
32. Palmer TD, Willhoite AR and Gage FH. Vascular niche for adult hippocampal neurogenesis. J Comp Neurol. 2000; 425:479-494. 33 Nowacka MM and Obuchowicz E. Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action. Neuropeptides. 2012;46:1-10.
33. Nowacka MM and Obuchowicz E. Vascular endothelial growth factor (VEGF) and its role in the central nervous system: a new element in the neurotrophic hypothesis of antidepressant drug action. Neuropeptides. 2012;46:1-10
34. Minelli A, Zanardini R, Abate M, Bortolomasi M, Gennarelli M and Bocchio-Chiavetto L. Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients. Prog Neuropsychopharmacology Biol psychiatry. 2011; 35:1322-1325.
35. Patel N, Moenkemeyer F, Germano S and Cheung MM. Plasma vascular endothelial growth factor A and placental growth factor: novel biomarkers of pulmonary hypertension in congenital diaphragmatic hernia. Am J Physiol Lung Cell Mol Physiol. 2015; 308:L378-383.
36. Verlohren S, Herraiz I, Lapaire O, Schlembach D, Zeisler H, Calda P, Sabria J, Markfeld-Erol F, Galindo A, Schoofs K, Denk B and Stepan H. New gestational phase-specific cutoffvalues for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension. 2014; 63:346-352.
37. Zawiejska A, Wender-Ozegowska E, Iciek R and Brazert J. Concentrations of endothelial nitric oxide synthase, angiotensin-converting enzyme, vascular endothelial growth factor and placental growth factor in maternal blood and maternal metabolic status in pregnancy complicated by hypertensive disorders. J Hum Hypertens. 2014; 28:670-676.
38. Cao Y, Linden P, Shima D, Browne F and Folkman J. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor. J Clin Invest. 1996; 98:2507-2511.
39. Fischer C, Mazzone M, Jonckx B and Carmeliet P. FLT1 and its ligands VEGFB and PlGF: drug targets for antiangiogenic therapy? Nat Rev Cancer. 2008; 8:942-956.
40. Denti L, Annoni V, Cattadori E, Salvagnini MA, Visioli S, Merli MF, Corradi F, Ceresini G, Valenti G, Hoffman AR and Ceda GP. Insulin-like growth factor 1 as a predictor of ischemic stroke outcome in the elderly. Am J Med. 2004; 117:312-317.
41. Guan J, Miller OT, Waugh KM, McCarthy DC and Gluckman PD. Insulin-like growth factor-1 improves somatosensory function and reduces the extent of cortical infarction and ongoing neuronal loss after hypoxia-ischemia in rats. Neuroscience. 2001; 105:299-306.
42. Torres-Aleman I. Toward a comprehensive neurobiology of IGF-I. Dev Neurobiol. 2010; 70:384-396.
43. Lang UE and Borgwardt S. Molecular Mechanisms of Depression:Perspectives on New Treatment Strategies. Cell Physiol Biochem 2013; 31:761-777.
44. Chaballe L, Schoenen J and Franzen R. Placental growth factor: a tissue modelling factor with therapeutic potentials in neurology? Acta Neurol Belg. 2011; 111:10-17.
45. Yue Y, Liu R, Lu J, Wang X, Zhang S, Wu A, Wang Q and Yuan Y. Reliability and validity of a new post-stroke depression scale in Chinese population. J Affect Disorders. 2015; 174:317-323.
46. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62.
47. Cockrell JR and Folstein MF. Mini-Mental State Examination (MMSE). Psychopharmacol Bull. 1988; 24:689-692.
48. Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif). 2001; 25:402-408.